BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36982631)

  • 1. Interest of Procalcitonin in ANCA Vasculitides for Differentiation between Flare and Infections.
    Poirot-Seynaeve X; Smets P; Pereira B; Olagne L; Stievenart J; Sapin V; Aumaitre O; Andre M; Trefond L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram.
    Zhang N; Sun J; Ji C; Bao X; Yuan C
    Clin Rheumatol; 2022 Nov; 41(11):3451-3460. PubMed ID: 35918562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and markers to identify pulmonary lesions caused by infection or vasculitis in AAV patients.
    Wang Y; Qu Z; Liang W; Chen X; Chen C; Cheng H; Hu H; Wei Z; Su K; Yang L; Wang H
    BMC Pulm Med; 2023 Jan; 23(1):27. PubMed ID: 36653805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.
    Eberhard OK; Haubitz M; Brunkhorst FM; Kliem V; Koch KM; Brunkhorst R
    Arthritis Rheum; 1997 Jul; 40(7):1250-6. PubMed ID: 9214425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis.
    Ajmani S; Singh H; Chaturvedi S; Mishra R; Rai MK; Jain A; Misra DP; Agarwal V
    Clin Rheumatol; 2019 Apr; 38(4):997-1005. PubMed ID: 30446886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of the neutrophil-to-lymphocyte ratio in the prediction of anti-neutrophil cytoplasmic antibody-associated vasculitis with infection.
    Liu R; Li M; Zhang L; Wang Y; Zhang Y; Li W; Liu S
    Clin Rheumatol; 2023 Feb; 42(2):471-477. PubMed ID: 36564556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological features of patients with antineutrophil cytoplasmic antibody-associated vasculitides concomitant with IgG4-related disease.
    Ma Y; Chen L; Xu Y; Han Q; Yu B; Yuan Y; Zhao J; Yang Y; Chen J; Han F
    Int J Rheum Dis; 2019 Dec; 22(12):2143-2150. PubMed ID: 31631507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prognostic risk factors of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Chen Z; Lin L; Yang W; Chen N; Lin Y
    Int Immunopharmacol; 2020 Oct; 87():106819. PubMed ID: 32717565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.
    Mosakowska M; Kania DB; Szamotulska K; Rymarz A; Niemczyk S
    BMC Nephrol; 2021 Aug; 22(1):290. PubMed ID: 34445984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.
    Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C
    Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DPB1 as a Risk Factor for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Cohort Study.
    Hilhorst M; Arndt F; Joseph Kemna M; Wieczorek S; Donner Y; Wilde B; Thomas Epplen J; van Paassen P; Cohen Tervaert JW
    Arthritis Rheumatol; 2016 Jul; 68(7):1721-30. PubMed ID: 26866715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 36165341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
    Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
    J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of procalcitonin measurement in the diagnosis of bacterial infections in patients with fever and flare of chronic gouty arthritis].
    Zhang J; Liu J; Long L; Zhou Q; Cheng J; Zhou B
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(31):2556-9. PubMed ID: 26711392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP levels in autoimmune disease can be specified by measurement of procalcitonin.
    Schwenger V; Sis J; Breitbart A; Andrassy K
    Infection; 1998; 26(5):274-6. PubMed ID: 9795783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.
    Musunuri B; Tripathy R; Padhi S; Panda AK; Das BK
    Clin Rheumatol; 2022 Nov; 41(11):3337-3344. PubMed ID: 35835900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
    Csernok E; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
    de Souza A; Westra J; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Kallenberg CG
    Arthritis Res Ther; 2013; 15(5):R104. PubMed ID: 24007972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.